IDH3A and central nervous system cancer: Known prognostic factors, such as age (specifically, patients older than 60 years), tumor grade (WHO III/IV), isocitrate dehydrogenase (IDH) mutation status, and the absence of 1p/19q codeletion, are associated with glioma malignancy and prognosis.